Evidence map›Paper›PMID 29399628›Full record

ArticleScience advances2018

In-air microfluidics enables rapid fabrication of emulsions, suspensions, and 3D modular (bio)materials.

Claas Willem Visser, Tom Kamperman, Lisanne P Karbaat, Detlef Lohse, Marcel Karperien

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 212 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Continuous Synthesis of Nanoscale Emulsions by Vapor Condensation (EVC).Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. Colloidal robotics.Nature materials · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Claas Willem VisserPhysics of Fluids Group, Faculty of Science and Technology, University of Twente, P.O. Box 217, 7500 AE Enschede, Netherlands.ORCID 0000-0003-3147-2003
Tom KampermanDepartment of Developmental BioEngineering, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, Netherlands.ORCID 0000-0002-2835-6709
Lisanne P KarbaatDepartment of Developmental BioEngineering, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, Netherlands.ORCID 0000-0001-7438-050X
Detlef LohsePhysics of Fluids Group, Faculty of Science and Technology, University of Twente, P.O. Box 217, 7500 AE Enschede, Netherlands.
Marcel KarperienDepartment of Developmental BioEngineering, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, Netherlands.ORCID 0000-0003-0751-0604
University of Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic chips provide unparalleled control over droplets and jets, which have advanced all natural sciences. However, microfluidic applications could be vastly expanded by increasing the per-channel throughput and directly exploiting the output of chips for rapid additive manufacturing. We unlock these features with in-air microfluidics, a new chip-free platform to manipulate microscale liquid streams in the air. By controlling the composition and in-air impact of liquid microjets by surface tension-driven encapsulation, we fabricate monodisperse emulsions, particles, and fibers with diameters of 20 to 300 μm at rates that are 10 to 100 times higher than chip-based droplet microfluidics. Furthermore, in-air microfluidics uniquely enables module-based production of three-dimensional (3D) multiscale (bio)materials in one step because droplets are partially solidified in-flight and can immediately be printed onto a substrate. In-air microfluidics is cytocompatible, as demonstrated by additive manufacturing of 3D modular constructs with tailored microenvironments for multiple cell types. Its in-line control, high throughput and resolution, and cytocompatibility make in-air microfluidics a versatile platform technology for science, industry, and health care.

Indexed as

AirPrinting, Three-DimensionalBiocompatible MaterialsEmulsionsHumansMesenchymal Stem CellsMicrofluidicsSuspensionsBiocompatible MaterialsEmulsionsSuspensions

Identifiers

PMID29399628
PMCPMC5792224
OpenAlexW2789674418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.